Effect of levocarnitine supplementation on myocardial strain in children with acute kidney injury receiving continuous kidney replacement therapy: a pilot study

Author(s):  
Kristen Sgambat ◽  
Sarah Clauss ◽  
Asha Moudgil
2021 ◽  
Vol 4 (8) ◽  
pp. e2121901
Author(s):  
Todd A. Wilson ◽  
Lawrence de Koning ◽  
Robert R. Quinn ◽  
Kelly B. Zarnke ◽  
Eric McArthur ◽  
...  

2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
Jonathan Chávez ◽  
Pablo Maggiani-Aguilera ◽  
Andres De la Torre-Quiroga ◽  
Alejandro Martínez-Gallardo Gonzalez ◽  
Ramón Medina-González ◽  
...  

Abstract Background and Aims Based on the pathophysiology of acute kidney injury (AKI) it is plausible that certain early interventions by the nephrologist could influence its trajectory. In this study, we investigated the impact of 5 early nephrology interventions on starting kidney replacement therapy (KRT), AKI progression and death. Method In a prospective cohort at Hospital Civil of Guadalajara, we followed-up for 10 days AKI patients in whom a nephrology consultation was requested. We analyzed 5 early interventions of the nephrology team (fluid adjustment, nephrotoxic withdrawal, antibiotic dose adjustment, nutritional adjustment and removal of hyperchloremic solutions) after propensity score and multivariate analysis for the risk of starting KRT (primary objective), AKI progression to stage 3 and death (secondary objectives). Results From 2017 to 2020 we analyzed 288 AKI patients. The mean age was 55.3 years, 60.7% were male, AKI KDIGO stage 3 was present in 50.5% of them, sepsis was the main etiology 50.3%, and 72 (25%) patients started KRT. The overall survival was 84.4%. Fluid adjustment was the only intervention associated with a decreased risk for starting KRT (OR 0.58, 95% CI 0.48-0.70, p = <0.001) and AKI progression to stage 3 (OR 0.59, 95% CI 0.49-0.71, p = <0.001). Receiving vasopressors and KRT were associated with mortality, but neither of these interventions reduced these risks. Conclusion In this prospective cohort study of AKI patients, we found for the first time that early nephrologist intervention and fluid prescription adjustment was associated with a reduction in the risk of starting KRT and progression to AKI stage 3.


Author(s):  
Rupesh Raina ◽  
Ronith Chakraborty ◽  
Andrew Davenport ◽  
Patrick Brophy ◽  
Sidharth Sethi ◽  
...  

Author(s):  
Mitra K. Nadim ◽  
Lui G. Forni ◽  
Ravindra L. Mehta ◽  
Michael J. Connor ◽  
Kathleen D. Liu ◽  
...  

AbstractKidney involvement in patients with coronavirus disease 2019 (COVID-19) is common, and can range from the presence of proteinuria and haematuria to acute kidney injury (AKI) requiring renal replacement therapy (RRT; also known as kidney replacement therapy). COVID-19-associated AKI (COVID-19 AKI) is associated with high mortality and serves as an independent risk factor for all-cause in-hospital death in patients with COVID-19. The pathophysiology and mechanisms of AKI in patients with COVID-19 have not been fully elucidated and seem to be multifactorial, in keeping with the pathophysiology of AKI in other patients who are critically ill. Little is known about the prevention and management of COVID-19 AKI. The emergence of regional ‘surges’ in COVID-19 cases can limit hospital resources, including dialysis availability and supplies; thus, careful daily assessment of available resources is needed. In this Consensus Statement, the Acute Disease Quality Initiative provides recommendations for the diagnosis, prevention and management of COVID-19 AKI based on current literature. We also make recommendations for areas of future research, which are aimed at improving understanding of the underlying processes and improving outcomes for patients with COVID-19 AKI.


Author(s):  
Helena Stockmann ◽  
Jan-Hendrik Bernhard Hardenberg ◽  
Annette Aigner ◽  
Christian Hinze ◽  
Inka Gotthardt ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document